Think Out Loud

OHSU Researcher Criticizes Drug Prices

Brian Druker, director of the Knight Cancer Institute at OHSU, is critical of pharmaceutical companies’ profit margins. He co-authored a newly published letter in a the medical journal Blood criticizing the expense of a drug he helped develop. That drug, Gleevec, is now used by over 200,000 cancer patients worldwide, and can cost up to $100,000 a year. Dr. Druker hopes to begin working with lawmakers to change the way pharmaceutical companies price their drugs.

Have you or a loved one been through cancer treatment? What were the financial barriers to your treatment? Would you support governmental regulating pharmaceutical pricing?


blog comments powered by Disqus

More Think Out Loud

More OPB

Follow Think Out Loud

Send Think Out Loud A Message